Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sagimet Biosciences Inc. | Director | Series A Common Stock | 1.9M | $7.79M | $4.10 | Jul 18, 2023 | Indirect |
Progyny, Inc. | Director | Common Stock | 228K | $7.28M | $31.95 | May 23, 2024 | Indirect |
Progyny, Inc. | Director | Common Stock | 43.4K | $1.39M | $31.95 | May 23, 2024 | Direct |
Sagimet Biosciences Inc. | Director | Series A Common Stock | 84.8K | $348K | $4.10 | Jul 18, 2023 | Direct |
Sagimet Biosciences Inc. | Director | Series A Common Stock | 46.9K | $192K | $4.10 | Jul 18, 2023 | By trust |
Atara Biotherapeutics, Inc. | Director | Common Stock | 116K | $45K | $0.39 | May 31, 2023 | Direct |
Atara Biotherapeutics, Inc. | Director | Common Stock | 197 | $76.60 | $0.39 | May 31, 2023 | Indirect |
Kyverna Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 736K | Feb 12, 2024 | Indirect | ||
ACELYRIN, Inc. | Director | Director Stock Option (right to buy) | 92.2K | Jun 7, 2024 | Direct | ||
Atara Biotherapeutics, Inc. | Director | Non-Qualified Stock Option (Right to Buy) | 79.5K | May 31, 2023 | Direct | ||
Sagimet Biosciences Inc. | Director | Stock Option (Right to Buy) | 51.5K | Jun 5, 2024 | Direct | ||
Progyny, Inc. | Director | Stock Option (Right to Buy) | 26.9K | May 23, 2024 | Direct | ||
Vera Therapeutics, Inc. | Director | Stock Option (right to buy) | 14K | May 15, 2024 | Direct | ||
Kyverna Therapeutics, Inc. | Director, 10%+ Owner | Series A-1 Redeemable Convertible Preferred Stock | 0 | Feb 12, 2024 | Indirect | ||
Kyverna Therapeutics, Inc. | Director, 10%+ Owner | Series A-2 Redeemable Convertible Preferred Stock | 0 | Feb 12, 2024 | Indirect | ||
Kyverna Therapeutics, Inc. | Director, 10%+ Owner | Series B Redeemable Convertible Preferred Stock | 0 | Feb 12, 2024 | Indirect | ||
Sagimet Biosciences Inc. | Director | Common Stock | 0 | Jul 18, 2023 | Indirect | ||
Sagimet Biosciences Inc. | Director | Series A Preferred Stock | 0 | Jul 18, 2023 | Indirect | ||
Sagimet Biosciences Inc. | Director | Series B-1 Preferred Stock | 0 | Jul 18, 2023 | Indirect | ||
Sagimet Biosciences Inc. | Director | Series B Preferred Stock | 0 | Jul 18, 2023 | Indirect | ||
Sagimet Biosciences Inc. | Director | Series C Preferred Stock | 0 | Jul 18, 2023 | Indirect | ||
Sagimet Biosciences Inc. | Director | Series D Preferred Stock | 0 | Jul 18, 2023 | Indirect | ||
Sagimet Biosciences Inc. | Director | Series E Preferred Stock | 0 | Jul 18, 2023 | Direct | ||
Sagimet Biosciences Inc. | Director | Series E Preferred Stock | 0 | Jul 18, 2023 | Indirect | ||
Sagimet Biosciences Inc. | Director | Series F Preferred Stock | 0 | Jul 18, 2023 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SLRN | ACELYRIN, Inc. | Jun 7, 2024 | 1 | $0 | 4 | Jun 11, 2024 | Director |
SGMT | Sagimet Biosciences Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
PGNY | Progyny, Inc. | May 23, 2024 | 2 | $0 | 4 | May 28, 2024 | Director |
VERA | Vera Therapeutics, Inc. | May 15, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
KYTX | Kyverna Therapeutics, Inc. | Feb 12, 2024 | 6 | $0 | 4 | Feb 14, 2024 | Director, 10%+ Owner |
KYTX | Kyverna Therapeutics, Inc. | Feb 7, 2024 | 0 | $0 | 3 | Feb 7, 2024 | Director, 10%+ Owner |
SGMT | Sagimet Biosciences Inc. | Jul 18, 2023 | 15 | $750K | 4 | Jul 20, 2023 | Director |
SGMT | Sagimet Biosciences Inc. | Jul 13, 2023 | 0 | $0 | 3 | Jul 13, 2023 | Director |
PGNY | Progyny, Inc. | Jun 23, 2023 | 2 | $0 | 4 | Jun 27, 2023 | Director |
PGNY | Progyny, Inc. | Jun 9, 2023 | 4 | $0 | 4 | Jun 13, 2023 | Director |
ATRA | Atara Biotherapeutics, Inc. | May 31, 2023 | 2 | $0 | 4 | Jun 2, 2023 | Director |
PGNY | Progyny, Inc. | May 24, 2023 | 3 | $65K | 4 | Jun 1, 2023 | Director |
VERA | Vera Therapeutics, Inc. | May 10, 2023 | 1 | $0 | 4 | May 12, 2023 | Director |
SLRN | ACELYRIN, Inc. | May 9, 2023 | 8 | $23.6M | 4 | May 11, 2023 | Director, 10%+ Owner |
SLRN | ACELYRIN, Inc. | May 4, 2023 | 1 | $0 | 4 | May 4, 2023 | Director, 10%+ Owner |
SLRN | ACELYRIN, Inc. | May 4, 2023 | 0 | $0 | 3 | May 4, 2023 | Director, 10%+ Owner |
VERA | Vera Therapeutics, Inc. | Mar 30, 2023 | 1 | $16.7K | 4 | Apr 3, 2023 | Director |
VERA | Vera Therapeutics, Inc. | Mar 28, 2023 | 1 | $173K | 4 | Mar 30, 2023 | Director |
VERA | Vera Therapeutics, Inc. | Mar 24, 2023 | 2 | $25.1K | 4 | Mar 28, 2023 | Director |
VERA | Vera Therapeutics, Inc. | Mar 17, 2023 | 2 | $637K | 4 | Mar 21, 2023 | Director |
VERA | Vera Therapeutics, Inc. | Mar 15, 2023 | 2 | $660K | 4 | Mar 17, 2023 | Director |
VERA | Vera Therapeutics, Inc. | Mar 10, 2023 | 1 | $343K | 4 | Mar 14, 2023 | Director |
VERA | Vera Therapeutics, Inc. | Mar 3, 2023 | 1 | $7.25K | 4 | Mar 7, 2023 | Director |
VERA | Vera Therapeutics, Inc. | Mar 1, 2023 | 2 | $170K | 4 | Mar 3, 2023 | Director |
VERA | Vera Therapeutics, Inc. | Feb 23, 2023 | 1 | $1.45K | 4 | Feb 27, 2023 | Director |
VERA | Vera Therapeutics, Inc. | Feb 13, 2023 | 1 | $72.5K | 4 | Feb 15, 2023 | Director |
VERA | Vera Therapeutics, Inc. | Feb 9, 2023 | 1 | $2.9K | 4 | Feb 13, 2023 | Director |
VERA | Vera Therapeutics, Inc. | Feb 3, 2023 | 4 | $2.21M | 4 | Feb 9, 2023 | Director |
PGNY | Progyny, Inc. | Oct 24, 2022 | 5 | $0 | 4 | Oct 26, 2022 | Director |
ATRA | Atara Biotherapeutics, Inc. | Jun 23, 2022 | 2 | $0 | 4 | Jun 27, 2022 | Director |
VERA | Vera Therapeutics, Inc. | May 24, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
PGNY | Progyny, Inc. | Dec 22, 2021 | 2 | $0 | 4 | Dec 27, 2021 | Director |
PGNY | Progyny, Inc. | Nov 17, 2021 | 4 | $0 | 4 | Nov 18, 2021 | Director |
PGNY | Progyny, Inc. | Sep 16, 2021 | 4 | $0 | 4 | Oct 26, 2021 | Director |
PGNY | Progyny, Inc. | Jul 19, 2021 | 2 | $0 | 4 | Jul 21, 2021 | Director |
PGNY | Progyny, Inc. | Jun 21, 2021 | 6 | $0 | 4 | Jun 23, 2021 | Director |
ATRA | Atara Biotherapeutics, Inc. | Jun 8, 2021 | 2 | $0 | 4 | Jun 9, 2021 | Director |
VERA | Vera Therapeutics, Inc. | May 18, 2021 | 6 | $0 | 4 | May 18, 2021 | Director |
VERA | Vera Therapeutics, Inc. | May 13, 2021 | 1 | $0 | 4 | May 17, 2021 | Director |
VERA | Vera Therapeutics, Inc. | May 13, 2021 | 0 | $0 | 3 | May 13, 2021 | Director |